Investigating the challenges in clinical transformation
Research gap analysis derived from 3 medicine papers in our local library.
The gap
Investigating the challenges in clinical transformation of microbiota-targeted strategies, - Analyzing the mechanism of action and experimental efficacy of each microbiota-targeted strategy, - Providing new practical ideas for PF treatment,
Evidence profile
Sourced from the stated challenges and future-work section of the source papers, classified as general, drawn from work published between 2024 and 2026, spanning 2 journals. Those papers have been cited 64 times in total.
Research trend
Established — well-defined area with open sub-problems.
Supporting evidence — 3 representative gaps
- Engineered probiotics for inflammatory bowel disease therapy: mechanisms, delivery strategies, and precision medicine (2026) · Frontiers in Microbiology · cited 19× · doi
Accurately predicting patient responses to probiotic treatments remains a primary difficulty. Ensuring that engineered probiotics retain their therapeutic functionality within the complex intestinal environment without causing irreversible disturbances to the host microbiota is a critical challenge. Long-term safety and stability of engineered probiotics are necessary to establish a scientific foundation for clinical application.
generalstated challengesKeywords: accurately predicting patient responses probiotic treatments remains primary - Rheumatoid arthritis and the intestinal microbiome: probiotics as a potential therapy (2024) · Frontiers in Immunology · cited 33× · doi
The unclear etiology and pathogenesis of RA pose a significant challenge for developing effective treatments. The complexity of the gut microbiota and its interactions with the immune system make it difficult to understand the mechanisms of probiotics in RA. The application of probiotics in RA is hindered by challenges such as standardization, regulation, and individual variability in response to probiotics.
generalstated challengesevidence 5/5Keywords: unclear etiology pathogenesis pose significant challenge developing effective - Lung-gut axis, intestinal microbiota, and pulmonary fibrosis: mechanisms and therapeutic potential (2025) · Frontiers in Microbiology · cited 12× · doi
Investigating the challenges in clinical transformation of microbiota-targeted strategies, - Analyzing the mechanism of action and experimental efficacy of each microbiota-targeted strategy, - Providing new practical ideas for PF treatment, - Exploring the potential of probiotic/prebiotic intervention, Fecal Microbiota Transplantation (FMT), diet and lifestyle adjustment, and antibiotic use in PF treatment
generalfuture-work sectionevidence 5/5Keywords: investigating challenges clinical transformation microbiota-targeted strategies analyzing mechanism
Questions about this gap
Explore this gap further
Run this gap as a query across open scholarly engines for the latest related literature.
Working on this gap? Review it with us.
Science AI Journal reviews manuscripts in one pass with 8 specialised AI agents calibrated on 69,000+ real peer reviews.
Tools for your next paper
Related gaps in Medicine
- The lack of prospective registration, independentThe lack of prospective registration, independent screening and extraction, and validated risk-of-bias assessment. The absence of a reproduc…
- Effect across methodologically diverse studies ratherEffect across methodologically diverse studies rather than as a uni- form effect expected in all populations. The findings are summarized in…
- There are certain concerns with According to this reviewThere are certain concerns with According to this review, biomarkers are playing an increasingly important role in cancer detection, prognos…
- That should be considered when interpreting the resultsthat should be considered when interpreting the results. First, the retrospective nature of the study may introduce biases related to data c…